Presenter: Yuehan Feng
Date: Tuesday, Sep 19, 2023, 11:45 AM – 1:00 PM
Session: PP03
Presenter: Ino Karemaker
Date: Monday, June 5
Topic area: Disease Biomarkers
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although immunotherapy has improved the treatment of NSCLC, a significant number of patients still fail to respond or develop resistance.
E-Poster presented at AACR 2020
Presenter: Jakob Vowinckel, PhD
A collaboration with: Indivumed GmbH
Presenter: Luca Räss
Oral Presentation at ASMS 2021
Session: Cancer Research
Date: Monday, November 1
Welcome to the Biognosys 3D Protein Explorer!
You can visualize the proteomic signature identified with our next-generation Plasma Biomarker Discovery solution in our latest pan-cancer study. We mapped each protein onto DeepMind’s AlphaFold2 protein structures and UniProt’s topological domains. We will keep expanding this portal to allow you to have a 3D view of the proteome.
Biognosys’ mass spectrometry technology and solutions search the complete proteome to quantify the most relevant proteins for your research. We offer multi-dimensional insights on protein expression, function, and structure to help you to unlock the complexity of biology and gain deeper insights for your biomarker discovery.
Learn more about our biomarker discovery offerings in biofluids and tissues.
The case study elaborates on the latest study on lung cancer we performed with our high-throughput TrueDiscovery™ platform for immunopeptidome profiling from needle-sized biopsies. We identified > 11,000 Class I and > 9,000 Class II immunopeptides on average.
Our partnership with precision oncology expert Indivumed uniquely supports our mission of deciphering biological complexity and pushing the boundaries of what is possible with our proteomics solutions to accelerate drug discovery and development in oncology.
In this video, our CBO, Kristina, and Indivumed’s Senior Director Oncology Analytics, Daniel, highlight what they value and enjoy in our partnership.
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
